By analyzing the clinical data of bladder cancer in the UALCAN database, we found that the expression of FGF11 is different in patients with different TNM stages, different pathological stages, different ages, and different genders, but the expression in tumor tissues is higher than that in normal tissue. This evidence concerns the gene FGF11 and neoplasm.